Implementing FDA added sugar labeling policy could generate substantial health gains and cost savings for the US population.

Between 2018 and 2037, a sugar label would prevent 354,400 cardiovascular disease and 599,300 diabetes mellitus cases, gain 727,000 quality-adjusted life-years, and save $31 billion in net healthcare costs or $61.9 billion in societal costs (incorporating reduced lost productivity and informal care costs). Source

Continue reading